Accueil・Liste d'Actions・Danaher Corp

Danaher Corp

Fermé

SecteurSoins de santé

202.44 -0.76

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

201

Max

203.87

Chiffres clés
By Trading Economics
Revenu	-159M 870M
Ventes	314M 6.3B
P/E Moyenne du Secteur	36.476 57.002
BPA	1.94
Rendement du dividende	0.7
Marge bénéficiaire	13.887
Employés	58,000
EBITDA	-364M 1.1B

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+7.79% upside

Dividendes
By Acuity
Rendement du dividende Moyenne du Secteur	0.70% 2.22%
Prochains Résultats	20 oct. 2026
Date du Prochain Dividende	30 oct. 2026
Date du Prochain Détachement de Dividende	25 sept. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	4.8B 147B
Ouverture précédente	203.2
Clôture précédente	202.44

Sentiment de l'Actualité

By Acuity

23%

77%

79 / 340 Classement par Healthcare

Danaher Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 août 2026, 20:06 UTC

Danaher Corp's shares are lower amid concerns over a surprising drop in U.S. retail sales, which fell 0.6% in July against expectations.

13 août 2026, 23:31 UTC

Danaher Corp shares rose in after-market trading, buoyed by unchanged producer prices in July and easing inflation concerns affecting investor sentiment.

12 août 2026, 23:46 UTC

Danaher Corp. shares were roughly flat in after-market trading, maintaining a position above its 20-day moving average and near the upper end of its one-month range.

10 août 2026, 19:42 UTC

Danaher Corp shares are higher today, supported by a broader rise in the Life Sciences Tools & Services sub-sector. The stock remains above its 20-day moving average.

7 août 2026, 19:36 UTC

News

Danaher Corp's stock is higher today, supported by significant insider transactions. The CFO and Executive Vice President reported acquiring substantial stock options.

6 août 2026, 20:02 UTC

Shares of Danaher Corp are higher, reflecting broader market gains since Wednesday's close. The stock is near the upper end of its one-month range.

5 août 2026, 19:51 UTC

Danaher Corp shares are higher today, supported by gains in the Life Sciences Tools & Services sub-sector. The stock has shown notable volatility during the session.

4 août 2026, 23:01 UTC

Danaher Corp shares are higher in after-market trading, supported by broader market optimism and easing oil prices contributing to favorable inflation expectations.

3 août 2026, 22:51 UTC

News

Danaher Corp appointed Julie Sawyer Montgomery as President and CEO, effective October 1, 2026. Shares are trading higher in after-market hours.

31 juil. 2026, 23:01 UTC

Danaher Corp shares are lower in after-market trading, with no specific news identified to explain the decline amid broader market weakness.

30 juil. 2026, 18:01 UTC

Danaher Corp. shares are lower today, fluctuating within their one-month range amid volatility influenced by the Federal Reserve's interest rate decisions.

29 juil. 2026, 23:01 UTC

Danaher Corp shares are higher in after-market trading, reflecting a slight increase since Wednesday's close. The stock reached a recent high shortly after 5:10 PM ET.

28 juil. 2026, 23:01 UTC

Danaher Corp shares declined in after-hours trading amid broader market losses linked to concerns over artificial intelligence spending and competition from Chinese chipmakers.

27 juil. 2026, 23:16 UTC

Danaher Corp shares are lower in after-market trading, declining slightly since Monday's close. No specific company news has been identified to explain the movement.

24 juil. 2026, 20:06 UTC

News

Danaher Corp shares are lower amid concerns over reduced sales growth in its biotechnology segment, despite raising full-year earnings guidance to $8.45-$8.60.

23 juil. 2026, 10:01 UTC

Danaher Corp shares are lower in pre-market trading, continuing a decline since Wednesday's close and remaining below the 20-day moving average.

22 juil. 2026, 22:01 UTC

Danaher Corp shares are trading lower in after-market hours, continuing a trend of six consecutive sessions finishing lower amid rising crude oil prices and market volatility.

21 juil. 2026, 19:41 UTC

News

Social Media

Danaher Corp shares are lower after the company issued a cautious fiscal 2026 revenue growth forecast despite reporting better-than-expected second-quarter earnings and revenues.

20 juil. 2026, 23:41 UTC

Danaher Corp shares declined in after-market trading, continuing a trend of lower finishes amid concerns over economic momentum and a drop in the leading economic index.

Comparaison

Variation de prix

Danaher Corp prévision

Objectif de Prix

By TipRanks

7.79% hausse

Prévisions sur 12 Mois

Moyen 219.78 USD 7.79%

Haut 240 USD

Bas 195 USD

Basé sur 20 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

20 ratings

Achat

Maintien

Vente

Basé sur 20 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

79 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.